| FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy (NCT00125762) | Afdhal, Nezam, M.D. | 2005-03-01 |
| Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection (NCT00239733) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment (NCT00167557) | The University of Texas Health Science Center, Houston | 2005-01-01 |
| A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis (NCT00562783) | Hospital Authority, Hong Kong | 2005-01-01 |
| A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C (NCT00246363) | Henry Sacks | 2005-01-01 |
| Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound (NCT01208311) | Northwell Health | 2004-12-01 |
| Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C (NCT00097045) | Intarcia Therapeutics | 2004-11-01 |
| Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247) (NCT00705107) | Merck Sharp & Dohme LLC | 2004-11-01 |
| Adult-to-Adult Living Donor Liver Transplantation Study (NCT00096733) | Arbor Research Collaborative for Health | 2004-10-01 |
| A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C (NCT00097435) | Human Genome Sciences Inc. | 2004-10-01 |
| Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI (NCT00154531) | National Taiwan University Hospital | 2004-08-01 |
| A Randomized Trial of Vaccine Adherence in Young Injection Drug Users (NCT00244374) | University of California, San Francisco | 2004-08-01 |
| Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression (NCT00205075) | University of Wisconsin, Madison | 2004-08-01 |
| Australian Trial in Acute Hepatitis C (NCT00192569) | Kirby Institute | 2004-07-01 |
| Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C (NCT00275548) | Mayo Clinic | 2004-07-01 |
| Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00078403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-07-01 |
| Reducing Depressive Symptoms During HCV Therapy: A Randomized Study (NCT00495768) | South Texas Veterans Health Care System | 2004-07-01 |
| Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients (NCT00085917) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-06-01 |
| Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation (NCT00821587) | University of Florida | 2004-06-01 |
| Short Course of Interferon Treatment in Patients With HCV Infection (NCT00502970) | Aga Khan University | 2004-05-01 |
| MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED) (NCT00857311) | Merck Sharp & Dohme LLC | 2004-05-01 |
| Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects (NCT00136214) | Beth Israel Deaconess Medical Center | 2004-03-01 |
| Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I (NCT00277758) | Weill Medical College of Cornell University | 2004-03-01 |
| Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection (NCT00164060) | Bayside Health | 2004-02-01 |
| Leukapheresis for Research on HCV-Coinfected Patients (NCT00076427) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-01-14 |
| Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C (NCT00203606) | University of Calgary | 2004-01-01 |
| The Ribavirin Pregnancy Registry (NCT00114712) | Syneos Health | 2004-01-01 |
| Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137) (NCT00686517) | Merck Sharp & Dohme LLC | 2003-12-01 |
| Health Behavior Feedback Study for Veterans With Hepatitis C (NCT00229580) | University of Washington | 2003-12-01 |
| VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients (NCT00108563) | US Department of Veterans Affairs | 2003-10-01 |
| Chronic Hepatitis Intervention Project for Drug Users (NCT00596843) | National Institute on Drug Abuse (NIDA) | 2003-09-01 |
| Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid (NCT00469131) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2003-09-01 |
| Chiron Corp HCV E1/E2 Vaccine (NCT00500747) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-08-01 |
| Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy (NCT00188240) | University Health Network, Toronto | 2003-08-01 |
| 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy. (NCT00069511) | United Therapeutics | 2003-07-01 |
| Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 (NCT00249574) | National Institute on Drug Abuse (NIDA) | 2003-06-01 |
| Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) (NCT00502788) | Carelon Research | 2003-05-01 |
| Study of the Immune Response to Hepatitis C Virus (NCT00237432) | Rockefeller University | 2003-04-01 |
| Treatment of Cholestatic Pruritus With Sertraline (NCT00058903) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-04-01 |
| Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 (NCT00056862) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-03-01 |
| Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) (NCT00564811) | UPECLIN HC FM Botucatu Unesp | 2003-03-01 |
| SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study (NCT00590564) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients (NCT00132210) | University Hospital, Bonn | 2002-09-01 |
| A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects (NCT00249860) | EMD Serono | 2002-09-01 |
| Hepatitis C Antiviral Resistance in African-Americans (NCT00038974) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2002-08-01 |
| Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection (NCT00163657) | Baylor Research Institute | 2002-07-01 |
| Pegintron Induction Therapy in HCV Non-Responders (NCT00363259) | Foundation for Liver Research | 2002-07-01 |
| Study to Reduce Intravenous Exposures (STRIVE) (NCT00391482) | National Institute on Drug Abuse (NIDA) | 2002-06-01 |
| Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection (NCT00158535) | ANRS, Emerging Infectious Diseases | 2002-06-01 |
| Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant (NCT00466219) | University Hospital, Geneva | 2002-05-01 |
| Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users (NCT00164372) | Centers for Disease Control and Prevention | 2002-05-01 |
| Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection (NCT00248339) | Virginia Commonwealth University | 2002-05-01 |
| Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 (NCT00277862) | Ain Shams University | 2002-04-01 |
| Treatment of Hepatitis C in Hemophilic Patients With HIV (NCT00055341) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin (NCT00031343) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC (NCT00207363) | Brooke Army Medical Center | 2002-02-01 |
| Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis (NCT00160940) | University Health Network, Toronto | 2002-02-01 |
| Timing and Duration of Acute Hepatitis C Treatment (NCT00241618) | Ain Shams University | 2002-01-01 |
| Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication (NCT00188201) | University Health Network, Toronto | 2002-01-01 |
| A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) (NCT00328549) | Ortho Biotech Products, L.P. | 2001-10-01 |
| Zidovudine Levels in HIV Infected Patients Being Treated for HCV (NCT00059358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. (NCT00383864) | Hospital Clinic of Barcelona | 2001-07-01 |
| Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients (NCT00018031) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| HCV/HIV Coinfection: Antiviral Therapy and Fibrosis (NCT01423643) | Johns Hopkins University | 2001-03-01 |
| Racial Difference in HCV/Host Interactions (NCT00071916) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00008463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| Immune Response to Hepatitis C Virus (NCT00006301) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-09-24 |
| NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection (NCT00315432) | Ortho Biotech Products, L.P. | 2000-09-01 |
| Genetics of Hepatitis C Virus Infection (NCT00005657) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-05-04 |
| Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV (NCT00004846) | National Institutes of Health Clinical Center (CC) | 1999-12-01 |
| Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies (NCT00004851) | National Institutes of Health Clinical Center (CC) | 1999-04-01 |
| Herbal Treatment of Hepatitis C in Methadone Maintained Patients (NCT00010816) | National Center for Complementary and Integrative Health (NCCIH) | 1998-09-01 |
| Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan (NCT00001712) | National Institutes of Health Clinical Center (CC) | 1998-02-01 |
| To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI). (NCT00007709) | US Department of Veterans Affairs | 1998-01-01 |
| Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016) (NCT03537274) | Merck Sharp & Dohme LLC | 1997-08-05 |
| EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV (NCT02699736) | Rigshospitalet, Denmark | 1994-01-01 |
| Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C (NCT00004804) | National Center for Research Resources (NCRR) | 1993-08-01 |
| History of Hepatitis C in Volunteer Blood Donors (NCT00001982) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1993-06-01 |
| Evaluation of Patients With Liver Disease (NCT00001971) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1992-05-27 |
| Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection (NCT00004850) | National Institutes of Health Clinical Center (CC) | 1991-03-15 |
| Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump (NCT01430000) | Medgenics Medical Israel Ltd. | |
| Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults (NCT00100581) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus (NCT00006643) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Prevalence of Hepatitis C Virus Infection in HIV-Infected Children (NCT00037076) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| TG4040 in Patients With Chronic HCV (NCT00449124) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C (NCT00930995) | Kaiser Permanente | |
| Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C (NCT00209118) | Emory University | |
| Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) (NCT00051077) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects (NCT01508286) | Janssen-Cilag International NV | |
| Effects of Ribavirin on Zidovudine or Stavudine (NCT00021632) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections (NCT00001035) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders (NCT00538811) | Aga Khan University | |
| Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection (NCT00015652) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis (NCT00023218) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C (NCT00239252) | Astellas Pharma Inc | |
| A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects (NCT00121017) | Abbott | |